Company / Free Cash Flow per Share
Stoke Therapeutics, Inc. Free Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.83
FY2025
5-year range
-$1.85 / $0.83
FY2021-FY2025
Trend
+146.2%
vs FY2024
Sector context
#51 of 192
Health Care
What the data says
At $0.83, Stoke Therapeutics, Inc.'s free cash flow per share ranks #51 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 8 years, ranging from $-16.77 in FY2018 to $0.83 in FY2025.
Based on SEC 10-K filings.
0.83 in FY2025.
Improved from $-0.91 to $0.83 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#51 of 192 in Health CareTop 27% of 192This company $0.83 Sector average -$19.84
▼
+104.2% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 146.2% year-over-year.
- Ranks #51 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.83 | +146.2% |
| FY2024 | -$1.80 | -98.2% |
| FY2023 | -$0.91 | +50.8% |
| FY2022 | -$1.85 | +0.4% |
| FY2021 | -$1.85 | -43.5% |
| FY2020 | -$1.29 | +29.0% |
| FY2019 | -$1.82 | +89.2% |
| FY2018 | -$16.77 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026